Substitution of serum supplements with chemically-defined components and creating defined media formulations optimized for cell culture is required for controlling the quality and consistency of cell therapy products. This result in a complex, large-scale optimization problem due to potentially uncharacterized factor effects and the large number of factors and dose levels involved, making conventional optimization methods unfeasible. In this study, a high-dimensional optimization (e.g. up to 15 factors and 6 dose levels) based on experimental feedback control provided a framework for the identification of serum-free media formulations for human primary cell expansion. The model-free approach utilized Differential Evolution principles as the...
Clinical use of umbilical cord blood has typically been limited by the need to expand hematopoietic ...
Duchenne Muscular Dystrophy (DMD) is a genetic disease affecting one boy out of 3500, which is due t...
The humanized monoclonal antibody (mAb) against the colon and ovarian cancer cells has been successf...
Substitution of serum supplements with chemically-defined components and creating defined media form...
Human pluripotent stem cells (hPSC) are used to study the early stages of human development in vitro...
The growing application of cell and gene therapies in humans leads to a need for cell type-optimized...
Biologics development leading to approval can take decades. Acceleration of this timeline is necessa...
Recent advances in genetic engineering have resulted in exponential growth in cell therapy technolog...
Optimizing media for biological processes, such as those used in tissue engineering and cultivated m...
Due to their immunosuppressive properties, mesenchymal stem cells (MSC) have been evaluated for the ...
Quality assurance is becoming increasingly important. Good laboratory practice (GLP) and Good manufa...
Regenerative medicine aims to not only treat, but also cure diseases and pathological conditions. Th...
Cell therapies have been recognized as a promising treatment for various diseases including a wide r...
Human mesenchymal stem cells (hMSCs) isolated from various tissues represent the most highly utilize...
HEK293 is a human cell line derived from embryonic kidney cells and is a frequently used system for ...
Clinical use of umbilical cord blood has typically been limited by the need to expand hematopoietic ...
Duchenne Muscular Dystrophy (DMD) is a genetic disease affecting one boy out of 3500, which is due t...
The humanized monoclonal antibody (mAb) against the colon and ovarian cancer cells has been successf...
Substitution of serum supplements with chemically-defined components and creating defined media form...
Human pluripotent stem cells (hPSC) are used to study the early stages of human development in vitro...
The growing application of cell and gene therapies in humans leads to a need for cell type-optimized...
Biologics development leading to approval can take decades. Acceleration of this timeline is necessa...
Recent advances in genetic engineering have resulted in exponential growth in cell therapy technolog...
Optimizing media for biological processes, such as those used in tissue engineering and cultivated m...
Due to their immunosuppressive properties, mesenchymal stem cells (MSC) have been evaluated for the ...
Quality assurance is becoming increasingly important. Good laboratory practice (GLP) and Good manufa...
Regenerative medicine aims to not only treat, but also cure diseases and pathological conditions. Th...
Cell therapies have been recognized as a promising treatment for various diseases including a wide r...
Human mesenchymal stem cells (hMSCs) isolated from various tissues represent the most highly utilize...
HEK293 is a human cell line derived from embryonic kidney cells and is a frequently used system for ...
Clinical use of umbilical cord blood has typically been limited by the need to expand hematopoietic ...
Duchenne Muscular Dystrophy (DMD) is a genetic disease affecting one boy out of 3500, which is due t...
The humanized monoclonal antibody (mAb) against the colon and ovarian cancer cells has been successf...